Patterns of Recurrence in Adenocarcinoma of the Esophagogastric Junction: ERECS Trial Post Hoc Analysis

The authors aimed to identify patterns of recurrence and predictive factors in patients with adenocarcinoma of the esophagogastric junction (AEG) following multimodal therapy. Their analysis of the ERECS trial revealed that distant recurrence is the primary cause of treatment failure, with specific predictors such as advanced pathologic stage and poor treatment response linked to higher systemic risk. The study suggests that tailored surveillance strategies for high-risk patients could improve outcomes, particularly as post-recurrence survival is notably better for those with single-site distant recurrence compared to multiple-site involvement.